• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndrome

June 19, 2020COVID-19, Vizit Graphs
Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndromeEftychia Lekka2020-08-03T14:03:26+00:00
Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndrome

Eculizumab is a biologic therapy, a complement C5 inhibitor, and has recently shown promise in COVID-19. The graph provides an important step towards elucidating the MoA of this drug in COVID-19.

Explore the live graph.

Tags: ACE, ACUTE RESPIRATORY DISTRESS SYNDROME, ALTERNATIVE, C5, COMPLEMENT ACTIVATION, COMPLEMENT C3, COMPLEMENT PATHWAY, COVID-19, ECULIZUMAB, GLOMERULAR FILTRATION RATE, GRAFT SURVIVAL, HEMOGLOBIN, HEMOLYSIS, IL6, IMMUNITY, PLATELET COUNT, SARS-COV-2

Post navigation

← Mechanistic analysis of Atorvastatin
Mechanistic analysis of Acalabrutinib (Calquence) →

Vizit Graphs Tag Cloud

APOPTOTIC PROCESS METFORMIN NFKB1 PD-1 CELL PROLIFERATION CANDIDA ALBICANS IL10 RAS LACTATE DEHYDROGENASE IFNG IL2 HELICOBACTER PYLORI INSULIN NEUTROPHILS CASP3 IL1B ALZHEIMER'S DISEASE TNF ACE COGNITION IL6 CD4 ESCHERICHIA COLI CELL DIFFERENTIATION ACE2 COAGULATION TMPRSS2 IMMUNE RESPONSE INFLAMMATION RHEUMATOID ARTHRITIS COVID-19 ANGIOTENSIN II IMMUNITY PSEUDOMONAS AERUGINOSA AUTOPHAGY STAPHYLOCOCCUS AUREUS MYALGIA INFLAMMATORY RESPONSE CANCER PARKINSON DISEASE LISTERIA MONOCYTOGENES ALBUMIN SARS-COV-2 INTERFERON AGING

© 2021 Biovista Vizit All Rights Reserved.